NfL is a structural axonal protein released in response to neuronal injury, elevated across a broad spectrum of neurodegenerative disorders, including multiple sclerosis, dementia, amyotrophic lateral sclerosis (ALS), and atypical parkinsonian disorders (APD) [7, 8]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.